2020
DOI: 10.1007/s10029-020-02226-2
|View full text |Cite
|
Sign up to set email alerts
|

Implementing preoperative Botulinum toxin A and progressive pneumoperitoneum through the use of an algorithm in giant ventral hernia repair

Abstract: Background Repair of large ventral hernias with loss of domain can be facilitated by preoperative Botulinum toxin A (BTA) injections and preoperative progressive pneumoperitoneum (PPP). The aim of this study is to evaluate the outcomes of ventral hernioplasty using a standardized algorithm, including component separation techniques, preoperative BTA and PPP. Methods All patients between June 2014 and August 2018 with giant hernias (either primary or incisional) of more than 12 cm width were treated according t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
21
0
10

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(31 citation statements)
references
References 33 publications
0
21
0
10
Order By: Relevance
“…Several groups with extensive BTX experience have developed specific treatment algorithms, describing precise indications (17)(18)(19). These algorithms often discuss BTX use in association with PPP, describing their separate indications and potential synergy-PPP potentially helping to stretch out pre-paralysed abdominal wall muscles (17).…”
Section: Indications and Use With Pppmentioning
confidence: 99%
See 1 more Smart Citation
“…Several groups with extensive BTX experience have developed specific treatment algorithms, describing precise indications (17)(18)(19). These algorithms often discuss BTX use in association with PPP, describing their separate indications and potential synergy-PPP potentially helping to stretch out pre-paralysed abdominal wall muscles (17).…”
Section: Indications and Use With Pppmentioning
confidence: 99%
“…Yurtkap et al describe another algorithm where BTX is given for facial defects 14-18 cm in size (18). If 18-22 cm in size, PPP is added for hernias with significant LOD; both PPP and BTX are used for fascial defects >22 cm.…”
Section: Indications and Use With Pppmentioning
confidence: 99%
“…Loss of domain ratio >20% or >25% 22,24,25,35 Measurements (hernia width or loss of domain ratio) 14,21,32,34,35 Hernia width >10 cm 23,30 Hernia width cut-off þ loss of domain ratio >20% 14,21 Surgeon preference or expected difficulty closing midline 11,27 Hernia contents cannot be reduced back to abdominal cavity 26 Foreseen problems during surgery 29 Open abdomen 12,28 Undefined/surgeon's decision 10,31,33,36 BT, Botulinum Toxin A; cm, centimeter; PP, progressive pneumoperitoneum.…”
Section: Pp Indications Bt Indicationsmentioning
confidence: 99%
“…to 500 units has been described, divided over 6 to 10 injection sites, in 2 or all 3 lateral abdominal muscle layers, and timeframes ranging from 45 to 6 days before surgery. 11,12,14,21,27,28,35 One study even described the use of BT injections on the day of surgery itself, barely allowing the BT to enter into force, and, therefore, the observed effects could be obelized as the result of a placebo effect. 11 The reported complications after the use of BT seemed minor; complications during or after the use of PP, however, were frequent and sometimes severe.…”
Section: Pp Indications Bt Indicationsmentioning
confidence: 99%
See 1 more Smart Citation